TISSUE THERAPIES
TISSUE THERAPIES operates in Diversified Metals & Mining.
TISSUE THERAPIES (1TT) - Net Assets
Latest net assets as of December 2023: €3.43 Million EUR
Based on the latest financial reports, TISSUE THERAPIES (1TT) has net assets worth €3.43 Million EUR as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.62 Million) and total liabilities (€191.41K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €3.43 Million |
| % of Total Assets | 94.71% |
| Annual Growth Rate | -17.21% |
| 5-Year Change | 18.63% |
| 10-Year Change | N/A |
| Growth Volatility | 115.41 |
TISSUE THERAPIES - Net Assets Trend (2015–2023)
This chart illustrates how TISSUE THERAPIES's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for TISSUE THERAPIES (2015–2023)
The table below shows the annual net assets of TISSUE THERAPIES from 2015 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €3.43 Million | -41.16% |
| 2022-12-31 | €5.82 Million | -13.39% |
| 2021-12-31 | €6.72 Million | +111.94% |
| 2020-12-31 | €3.17 Million | +9.83% |
| 2019-12-31 | €2.89 Million | +255.09% |
| 2018-12-31 | €813.44K | -94.76% |
| 2015-12-31 | €15.52 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to TISSUE THERAPIES's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2119200200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €88.88 Million | 2593.75% |
| Total Equity | €3.43 Million | 100.00% |
TISSUE THERAPIES Competitors by Market Cap
The table below lists competitors of TISSUE THERAPIES ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VistaREIT Inc.
PSE:VREIT
|
$212.63 |
|
NATURAL COOL - Dusseldorf Stock Exchang
DU:N7E
|
$212.78 |
|
Mobile Tornado Group plc
LSE:MBT
|
$212.80 |
|
American Nortel Communications Inc
PINK:ARTM
|
$213.62 |
|
NordTelekom Telecommunications Service Provider Nyrt.
BUD:NORD
|
$210.88 |
|
Moliera2 S.A.
WAR:MO2
|
$210.73 |
|
DGWG
JK:DGWG
|
$210.46 |
|
Braveheart Investment Group
LSE:BRH
|
$210.06 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in TISSUE THERAPIES's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 5,823,323 to 3,426,634, a change of -2,396,689 (-41.2%).
- Net loss of 2,410,993 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-2.41 Million | -70.36% |
| Other Changes | €14.30K | +0.42% |
| Total Change | €- | -41.16% |
Book Value vs Market Value Analysis
This analysis compares TISSUE THERAPIES's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.42x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.54x to 1.42x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | €0.01 | €0.02 | x |
| 2018-12-31 | €0.00 | €0.02 | x |
| 2019-12-31 | €0.00 | €0.02 | x |
| 2020-12-31 | €0.03 | €0.02 | x |
| 2021-12-31 | €0.03 | €0.02 | x |
| 2022-12-31 | €0.03 | €0.02 | x |
| 2023-12-31 | €0.02 | €0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently TISSUE THERAPIES utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -70.36%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.06x
- Recent ROE (-70.36%) is above the historical average (-188.82%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -74.82% | 0.00% | 0.00x | 1.06x | €-13.16 Million |
| 2016 | -54.26% | 0.00% | 0.00x | 0.00x | €-6.63 Million |
| 2018 | -1346.87% | 0.00% | 0.00x | 3.41x | €-11.04 Million |
| 2019 | 57.77% | 0.00% | 0.00x | 1.08x | €1.38 Million |
| 2020 | 8.89% | 0.00% | 0.00x | 1.03x | €-35.24K |
| 2021 | -15.87% | 0.00% | 0.00x | 1.02x | €-1.74 Million |
| 2022 | -14.99% | 0.00% | 0.00x | 1.01x | €-1.46 Million |
| 2023 | -70.36% | 0.00% | 0.00x | 1.06x | €-2.75 Million |
Industry Comparison
This section compares TISSUE THERAPIES's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| TISSUE THERAPIES (1TT) | €3.43 Million | -74.82% | 0.06x | $211.60 |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |